228 related articles for article (PubMed ID: 33908611)
1. High prevalence of Cryptococcal antigenemia using a finger-prick lateral flow assay in individuals with advanced HIV disease in Santarém Municipality, Brazilian Amazon Basin.
Assy JGPL; Said RDC; Pinheiro OC; Brandão ADS; Boulware DR; França FOS; Vidal JE
Med Mycol; 2021 Sep; 59(9):909-915. PubMed ID: 33908611
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of central nervous system cryptococcosis using a fingerprick whole-blood lateral flow assay in individuals with neurological symptoms and advanced HIV disease in a Brazilian emergency department.
Oliveira FG; Nakagawa JAS; de Oliveira JMM; Júnior RML; Marcusso R; Vidal JE
Med Mycol; 2023 Sep; 61(9):. PubMed ID: 37656871
[TBL] [Abstract][Full Text] [Related]
3. Asymptomatic cryptococcal antigen prevalence detected by lateral flow assay in hospitalised HIV-infected patients in São Paulo, Brazil.
Vidal JE; Toniolo C; Paulino A; Colombo A; Dos Anjos Martins M; da Silva Meira C; Pereira-Chioccola VL; Figueiredo-Mello C; Barros T; Duarte J; Fonseca F; Alves Cunha M; Mendes C; Ribero T; Dos Santos Lazera M; Rajasingham R; Boulware DR
Trop Med Int Health; 2016 Dec; 21(12):1539-1544. PubMed ID: 27699970
[TBL] [Abstract][Full Text] [Related]
4. Brief Report: Point of Care Cryptococcal Antigen Screening: Pipetting Finger-Prick Blood Improves Performance of Immunomycologics Lateral Flow Assay.
Wake RM; Jarvis JN; Harrison TS; Govender NP
J Acquir Immune Defic Syndr; 2018 Aug; 78(5):574-578. PubMed ID: 29771787
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and mortality of cryptococcal disease in adults with advanced HIV in an urban tertiary hospital in Sierra Leone: a prospective study.
Lakoh S; Rickman H; Sesay M; Kenneh S; Burke R; Baldeh M; Jiba DF; Tejan YS; Boyle S; Koroma C; Deen GF; Beynon F
BMC Infect Dis; 2020 Feb; 20(1):141. PubMed ID: 32059703
[TBL] [Abstract][Full Text] [Related]
6. Multicenter Cryptococcal Antigen Screening of HIV-Infected Patients in Iran.
Bandalizadeh Z; Shokohi T; Moosazadeh M; Keikha N; Seyedpor H; Rabie Rudsari M; Babamahmoudi F; Ghasemian R; Mardani M; Javanian M; Soleimanpour S; Sefidgar AA; Shokri M; Gouya MM; Seyedmousavi S
Curr Microbiol; 2020 Aug; 77(8):1667-1672. PubMed ID: 32296917
[TBL] [Abstract][Full Text] [Related]
7. Identification of Cryptococcus antigen in human immunodeficiency virus-positive Turkish patients by using the Dynamiker
Karaman E; Ilkit M; Kuşçu F
Mycoses; 2019 Oct; 62(10):961-968. PubMed ID: 31344286
[TBL] [Abstract][Full Text] [Related]
8. Finger-Prick Whole Blood Cryptococcal Antigen Lateral Flow Assay for the Diagnosis of Cryptococcosis in HIV-Negative Patients: A Case Series Study in Two Tertiary Centers in São Paulo, Brazil.
Vidal JE; Oliveira FG; Vieira M; Pereira L; Lucas Junior RM; Guedes BF; Magri MC; Boulware DR
J Fungi (Basel); 2023 Nov; 9(12):. PubMed ID: 38132741
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of cryptococcal infection among advanced HIV patients in Argentina using lateral flow immunoassay.
Frola C; Guelfand L; Blugerman G; Szyld E; Kaufman S; Cahn P; Sued O; Pérez H
PLoS One; 2017; 12(6):e0178721. PubMed ID: 28617817
[TBL] [Abstract][Full Text] [Related]
10. Serum Cryptococcal Antigen Testing in Immunosuppressed HIV-positive Children and Adolescents.
Zuma P; Ramsamy Y; Mlisana K; Archary M
Pediatr Infect Dis J; 2020 Mar; 39(3):217-220. PubMed ID: 31725553
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis and budgetary impact of the Cryptococcal Antigen Lateral Flow Assay (CRAG-LFA) implementation for the screening and diagnosis of cryptococcosis in asymptomatic people living with HIV in Brazil.
Vianna CMM; Mosegui GBG
Rev Inst Med Trop Sao Paulo; 2021; 63():e57. PubMed ID: 34231822
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings.
Meya DB; Manabe YC; Castelnuovo B; Cook BA; Elbireer AM; Kambugu A; Kamya MR; Bohjanen PR; Boulware DR
Clin Infect Dis; 2010 Aug; 51(4):448-55. PubMed ID: 20597693
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and outcomes of cryptococcal antigenemia in HIV-seropositive patients hospitalized for suspected tuberculosis in Uganda.
Andama AO; den Boon S; Meya D; Cattamanchi A; Worodria W; Davis JL; Walter ND; Yoo SD; Kalema N; Haller B; Huang L;
J Acquir Immune Defic Syndr; 2013 Jun; 63(2):189-94. PubMed ID: 23542636
[TBL] [Abstract][Full Text] [Related]
14. Cryptococcal antigenemia prevalence and clinical data in HIV-infected patients from the reference centre at INI-FIOCRUZ, Rio de Janeiro, Southeast of Brazil.
Ferreira MF; Brito-Santos F; Trilles L; Almeida MA; Wanke B; Veloso VG; Nunes EP; Lazera MDS
Mycoses; 2020 Feb; 63(2):145-150. PubMed ID: 31715053
[TBL] [Abstract][Full Text] [Related]
15. Magnitude of Cryptococcal Antigenemia among HIV Infected Patients at a Referral Hospital, Northwest Ethiopia.
Derbie A; Ayalew W; Mekonnen D; Alemu M; Mulugeta Y
Ethiop J Health Sci; 2018 Jul; 28(4):369-374. PubMed ID: 30607049
[TBL] [Abstract][Full Text] [Related]
16. Utility of urine and serum lateral flow assays to determine the prevalence and predictors of cryptococcal antigenemia in HIV-positive outpatients beginning antiretroviral therapy in Mwanza, Tanzania.
Magambo KA; Kalluvya SE; Kapoor SW; Seni J; Chofle AA; Fitzgerald DW; Downs JA
J Int AIDS Soc; 2014; 17(1):19040. PubMed ID: 25109284
[TBL] [Abstract][Full Text] [Related]
17. Cryptococcal antigenemia and associated risk factors among ART-naïve and ART-experienced HIV-infected peoples at selected health institutions of Mekelle, Northern Ethiopia.
Hailu K; Niguse S; Hagos K; Abdulkader M
Microbiologyopen; 2019 Jun; 8(6):e00746. PubMed ID: 30277315
[TBL] [Abstract][Full Text] [Related]
18. Cryptococcal antigen prevalence in HIV-infected Tanzanians: a cross-sectional study and evaluation of a point-of-care lateral flow assay.
Rugemalila J; Maro VP; Kapanda G; Ndaro AJ; Jarvis JN
Trop Med Int Health; 2013 Sep; 18(9):1075-1079. PubMed ID: 23937699
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cryptococcal antigenemia between antiretroviral naïve and antiretroviral experienced HIV positive patients at two hospitals in Ethiopia.
Beyene T; Woldeamanuel Y; Asrat D; Ayana G; Boulware DR
PLoS One; 2013; 8(10):e75585. PubMed ID: 24124498
[TBL] [Abstract][Full Text] [Related]
20. Screening for cryptococcal antigenemia using the lateral flow assay in antiretroviral therapy-naïve HIV-positive adults at an Ethiopian hospital clinic.
Reepalu A; Balcha TT; Yitbarek T; Jarso G; Sturegård E; Björkman P
BMC Res Notes; 2015 Nov; 8():702. PubMed ID: 26597840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
